Enable Injections

Cincinnati, United States Founded: 2010 • Age: 16 yrs
Provider of a wearable drug delivery solution

About Enable Injections

Enable Injections is a Healthcare company based in Cincinnati (United States) founded in 2010 by Mike Hooven. Enable Injections has raised $334.27 million across 11 funding rounds from investors including Cincinnati Children’s, Grosvenor Capital Management and Sanofi. The company has 185 employees. Its chief executive, as recorded, is Mike Hooven. Its website enableinjections.com draws about 10 thousand monthly visits. Enable Injections offers products and services including enFuse Wearable, enFuse Transfer Systems, enFuse Smart Technology, and Empaveli. Its focus areas include Life Sciences, Drug Delivery, Patches and Microneedle Patch. Its competitors include Micron Biomedical, Zosano Pharma and SkinJect; 3 of its 3 listed competitors have raised funding.

Company details

Provider of a wearable drug delivery solution. The companys drug delivery device include enFuse for injectable therapies which enables a range of flexible delivery options for patients and healthcare providers, including a range of viscosities, volumes, delivery times, and sites for administration.

Key Metrics
  • Total Equity Funding
    $334.27M (USD)

    in 11 rounds

  • Latest Funding Round
    $30M (USD), Series C

    Jan 2026

  • Investors
  • Employee Count
    185

Products & Services of Enable Injections

Enable Injections offers a comprehensive portfolio of products and services, including enFuse Wearable, enFuse Transfer Systems, enFuse Smart Technology, and Empaveli.

enFuse Wearable
Drug Delivery Platform

Wearable device for hands-free subcutaneous medication delivery.

enFuse Transfer Systems
Drug Delivery Technology

Systems for transferring medications in wearable formats.

enFuse Smart Technology
Smart Medical Devices

Intelligent features for monitoring and administering drugs.

Empaveli
Therapeutic Product

Wearable injector for specific drug therapies.

Funding Insights of Enable Injections

Enable Injections has successfully raised a total of $334.27M across 11 strategic funding rounds. The most recent funding activity was a Series C round of $30 million completed in January 2026. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding $334.27M
  • Total Rounds 11
  • Last Round Series C — $30M
  • Investors Count 12

Latest 10 of 11 funding rounds of Enable Injections with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Jan 2026$30MSeries C––
Jan 2022$215MSeries C–Magnetar
Sep 2020$25MDebt – Conventional––
Oct 2018$50MSeries B–Sanofi
Nov 2016$30MSeries A–ORI Capital
Aug 2016$2MSeries A––
–
Aug 2016$5MSeries A––
–
Apr 2016$2MSeed––
–
May 2015$247,250Seed––
–
Jun 2014$22,925Seed––
–
Valuation history

12 investors in total: 12 institutional.

Investors in Enable Injections

Enable Injections has secured backing from 12 investors, including venture fund and institutional investors. Prominent investors backing the company include Cincinnati Children’s, Grosvenor Capital Management and Sanofi.

All
Venture Fund
Institutional
InvestorDescriptionFounded YearDomainLocation
Magnetar Capital is engaged in alternative asset management.
magnetar.comEvanston, United States
Private fund focused on debt and equity investments in real estate and multiple sectors
1762barings.comLondon, United Kingdom
Early-stage sector-agnostic VC firm investing in geographies such as the US
ohioinnovationfund.comColumbus, United States
CincyTech is engaged in venture capital investments for innovative startups.
cincytechusa.comCincinnati, USA
Venture debt firm focused on the life sciences sector
2002oxfordfinance.comAlexandria, United States
A venture capital firm focused on early-stage biotech investments.
2015ori-capital.comHong Kong, Hong Kong
Multi-strategy hedge fund and fund of funds focused on multiple sectors
1971gcmgrosvenor.comChicago, United States
Global investment manager employing quantitative strategies and advanced technology platforms.
2014squarepoint-capital.comNew York, United States
Pediatric healthcare services are delivered through a hospital chain.
1883cincinnatichildrens.orgUnited States
cintrifuse.com
Premium access

Investor details for Enable Injections

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

People of Enable Injections

24 people are tracked at Enable Injections (13 in leadership, 7 in board & advisors, 4 in team); the tracked headcount is 185.

NameRoleGroup
Mike Hooven
Founder & CEOLeadership
Matthew J. Huddleston
EVP, Business Development, & CTOLeadership
Eileen Rogers
SVP, Program General ManagerLeadership
Michael D. Hooven
President & CEOLeadership
Mike H.
Director Of Supply ChainLeadership
Tim Flaherty
EVP & CFOLeadership
Russ Pagano
VP, Quality & Regulatory AffairsLeadership
Gwendolyn Payne
Director Of Regulatory AffairsLeadership
Jeff Kaufhold
Director Of Quality AssuranceLeadership
Greg Etter
Vice President Of Engineering And AutomationLeadership
Baret Kilbacak
Associate Director, Quality EngineeringLeadership
Jessica Byerly
Senior Director Human ResourcesLeadership
Katie Petry McDonnell
Senior Director, Program ManagementLeadership
Nigel Sheail
DirectorBoard & advisors
Richard J. D’Augustine
DirectorBoard & advisors
John Rice
DirectorBoard & advisors
Simone Song
DirectorBoard & advisors
John DeFord
DirectorBoard & advisors
Jim Collins
DirectorBoard & advisors
Beckie Robertson
DirectorBoard & advisors

4 more people are available in the full profile.

Premium access

Complete people profiles for Enable Injections

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Timeline of Enable Injections

3 dated milestones of Enable Injections across 16 years, from founding to its latest funding, stage changes and deals.

  1. Founded Enable Injections is founded.
  2. Funding First funding round.
  3. Funding Latest funding round, Series C, of $30.0M.

Competitors of Enable Injections

Enable Injections has 3 listed competitors in our database, 3 of them funded. They include Micron Biomedical, Zosano Pharma and SkinJect.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
micronbiomedical.com2014Atlanta, United States$33M11
Microneedle patches are developed for vaccine and drug delivery.
zosanopharma.com2006Fremont, United States$147.16M40
Develops innovative transdermal drug delivery technologies for various therapeutic applications.
skinjectpatch.com2015Pittsburgh, United States$3.4M
Dissolvable microneedle patches for non-melanoma skin cancer treatment are developed.
Premium access

Detailed competitors of Enable Injections

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Web traffic of Enable Injections

The website of Enable Injections (enableinjections.com) receives about 10.3K visits a month.

  • Monthly visits
    10.3K

    ▲ 49.1% vs previous month

Similar websites

Websites whose visitors overlap most with Enable Injections. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
ondrugdelivery.com
100%
#833,579View details

Top companies in Biopharma Outsourcing & Drug Delivery

3 companies that operate in the same segment as Enable Injections (Biopharma Outsourcing & Drug Delivery) in United States, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Suite solutions are provided for payers and healthcare providers.
1998Princeton, New Jersey, United StatesUSD 220 MUSD 374.1 M5,666
Wearable insulin infusion systems are developed for diabetes patients.
2000Boston, Massachusetts, United StatesUSD 120.4 MUSD 2.71 B3,900
Developer of small-molecule drugs
1991Los Angeles, California, United StatesUSD 50 MUSD 348.97 M407
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • âś“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • âś“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • âś“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Enable Injections

Premium access

Complete news archive for Enable Injections

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Enable Injections

Enable Injections was founded in 2010 and raised its 1st funding round 1 year after it was founded.

Enable Injections is headquartered in Cincinnati, United States. It is registered at Cincinnati, Ohio, United States.

Mike Hooven is the CEO of Enable Injections, as recorded in our data. They have also founded this company.

Enable Injections is a funded company, having raised a total of $334.27M across 11 funding rounds to date. The company's 1st funding round was a Seed of $22.93K, raised on Apr 2011.

Enable Injections has 185 employees.

Provider of a wearable drug delivery solution. The companys drug delivery device include enFuse for injectable therapies which enables a range of flexible delivery options for patients and healthcare providers, including a range of viscosities, volumes, delivery times, and sites for administration.

Enable Injections's top competitors include Micron Biomedical, SkinJect and Zosano Pharma.

Enable Injections offers enFuse Wearable, enFuse Transfer Systems, enFuse Smart Technology, and Empaveli.

Enable Injections has 12 investors. Key investors include Cincinnati Children’s, Grosvenor Capital Management, Sanofi, Barings, and Oxford Finance.

Enable Injections operates through Enable Injections.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available